177 related articles for article (PubMed ID: 8833765)
1. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies.
Naoi M; Maruyama W; Dostert P; Hashizume Y; Nakahara D; Takahashi T; Ota M
Brain Res; 1996 Feb; 709(2):285-95. PubMed ID: 8833765
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of N-methyl(R)salsolinol: involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines.
Naoi M; Maruyama W; Kasamatsu T; Dostert P
J Neural Transm Suppl; 1998; 52():125-38. PubMed ID: 9564615
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
Naoi M; Maruyama W; Dostert P; Hashizume Y
J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
[TBL] [Abstract][Full Text] [Related]
4. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain.
Antkiewicz-Michaluk L; Romañska I; Papla I; Michaluk J; Bakalarz M; Vetulani J; Krygowska-Wajs A; Szczudlik A
Neuroscience; 2000; 96(1):59-64. PubMed ID: 10683410
[TBL] [Abstract][Full Text] [Related]
6. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
Maruyama W; Dostert P; Matsubara K; Naoi M
Free Radic Biol Med; 1995 Jul; 19(1):67-75. PubMed ID: 7635360
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: in vivo and in vitro studies.
Maruyama W; Dostert P; Naoi M
J Neurochem; 1995 Jun; 64(6):2635-43. PubMed ID: 7760044
[TBL] [Abstract][Full Text] [Related]
8. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.
Lorenc-Koci E; Smiałowska M; Antkiewicz-Michaluk L; Gołembiowska K; Bajkowska M; Wolfarth S
Neuroscience; 2000; 95(4):1049-59. PubMed ID: 10682712
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of endogenous isoquinolines to human dopaminergic neuroblastoma SH-SY5Y cells.
Takahashi T; Maruyama W; Deng Y; Dostert P; Nakahara D; Niwa T; Ohta S; Naoi M
J Neural Transm (Vienna); 1997; 104(1):59-66. PubMed ID: 9085193
[TBL] [Abstract][Full Text] [Related]
11. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
[TBL] [Abstract][Full Text] [Related]
12. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
Nagatsu T; Yoshida M
Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res Bull; 2001 Sep; 56(1):55-60. PubMed ID: 11604249
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M; Maruyama W; Nagy GM
Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: a microdialysis study.
Nakahara D; Maruyama W; Hashiguti H; Naoi M
Brain Res; 1994 May; 644(2):226-32. PubMed ID: 8050034
[TBL] [Abstract][Full Text] [Related]
16. Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease.
Zhu W; Wang D; Zheng J; An Y; Wang Q; Zhang W; Jin L; Gao H; Lin L
Clin Chem; 2008 Apr; 54(4):705-12. PubMed ID: 18238832
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons.
Naoi M; Maruyama W; Akao Y; Zhang J; Parvez H
Toxicology; 2000 Nov; 153(1-3):123-41. PubMed ID: 11090952
[TBL] [Abstract][Full Text] [Related]
18. [Studies on endogenous toxins as pathogenic factors in idiopathic parkinson's disease].
Maruyama W; Naoi M
Nihon Yakurigaku Zasshi; 2000 Dec; 116(6):333-42. PubMed ID: 11188501
[TBL] [Abstract][Full Text] [Related]
19. Selective release of serotonin by endogenous alkaloids, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, (R)- and (S)salsolinol, in the rat striatum; in vivo microdialysis study.
Maruyama W; Nakahara D; Dostert P; Hashiguchi H; Ohta S; Hirobe M; Takahashi A; Nagatsu T; Naoi M
Neurosci Lett; 1993 Jan; 149(2):115-8. PubMed ID: 8474680
[TBL] [Abstract][Full Text] [Related]
20. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Naoi M; Kasamatsu T; Hashizume Y; Takahashi T; Kohda K; Dostert P
J Neurochem; 1997 Jul; 69(1):322-9. PubMed ID: 9202326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]